The molecular mechanism of how PRBR reduced hypertension might be (i) the inhibition of the renin–angiotensin axis, (ii) the inhibition of fibrosis, or (iii) the inhibition of oxidative-stress-generating enzymes (NOX) and the activation of an antioxidant enzyme (GPx). The gene discussed is REN; the disease is hypertensive disorder.